SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-007008
Filing Date
2015-08-11
Accepted
2015-08-11 16:12:57
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cdtx-10q_20150630.htm 10-Q 1037000
2 EX-31.1 cdtx-ex311_6.htm EX-31.1 9532
3 EX-31.2 cdtx-ex312_9.htm EX-31.2 9379
4 EX-32.1 cdtx-ex321_8.htm EX-32.1 6452
5 EX-32.2 cdtx-ex322_7.htm EX-32.2 6312
  Complete submission text file 0001564590-15-007008.txt   3660607

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cdtx-20150630.xml EX-101.INS 567475
7 XBRL TAXONOMY EXTENSION SCHEMA cdtx-20150630.xsd EX-101.SCH 34747
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cdtx-20150630_cal.xml EX-101.CAL 25057
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cdtx-20150630_def.xml EX-101.DEF 149835
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cdtx-20150630_lab.xml EX-101.LAB 289582
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cdtx-20150630_pre.xml EX-101.PRE 213244
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 151044046
SIC: 2836 Biological Products, (No Diagnostic Substances)